MENU

ETON Stock Tickeron detected bullish Stock Pattern: Rectangle Bottom ETON on April 22, 2025, netting in a 25.40% gain over 1 month

A.I.dvisor
at Tickeron.com
Loading...
+25.40% Gain from a Successful pattern Rectangle Bottom
ETON - Eton Pharmaceuticals
Tickeron
Ticker: ETON
Company: Eton Pharmaceuticals
Gain: +25.4%
Confirmed: 04/22/25
Succeeded: 05/07/25
Total length: 43 days
On March 25, 2025, A.I.dvisor detected a Rectangle Bottom Pattern (Bullish) for Eton Pharmaceuticals (ETON, $13.74). On April 22, 2025, A.I.dvisor confirmed the Bullish pattern, setting a target price of $17.52. 15 days later, on May 07, 2025, ETON reached the target price resulting in a +2 for traders who took a long position in the stock.

Momentum Indicator for ETON turns positive, indicating new upward trend

ETON saw its Momentum Indicator move above the 0 level on April 14, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 105 similar instances where the indicator turned positive. In of the 105 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for ETON just turned positive on April 14, 2025. Looking at past instances where ETON's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .

ETON moved above its 50-day moving average on April 22, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ETON crossed bullishly above the 50-day moving average on April 25, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ETON advanced for three days, in of 278 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 231 cases where ETON Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 16 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ETON declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ETON’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.223) is normal, around the industry mean (61.504). P/E Ratio (49.333) is within average values for comparable stocks, (90.857). ETON's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.987). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (3.040) is also within normal values, averaging (19.413).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
ETON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of sterile injectable products

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
21925 West Field Parkway
Phone
+1 847 787-7361
Employees
30
Web
https://www.etonpharma.com